SCHEMBL5658731

SCHEMBL5658731

Cc1cc(C2(c3cc(C)c(O)c(C)c3)C(=O)N(C)c3ccccc32)cc(C)c1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.52
GPR55 Q9Y2T6 2/20 0.52
PKM P14618 2/20 0.52
MAPT P10636 5/20 0.48
LMNA P02545 4/20 0.48
KDM4E B2RXH2 1/20 0.48
HCRTR1 O43613 1/20 0.48
RAD52 P43351 1/20 0.43
ALDH1A1 P00352 3/20 0.42
TSHR P16473 1/20 0.41
USP2 O75604 1/20 0.41
ALOX15 P16050 1/20 0.41
MAPK1 P28482 1/20 0.40
CBX7 O95931 1/20 0.40
CDYL2 Q8N8U2 1/20 0.40
CDYL Q9Y232 1/20 0.40
CDY1; CDY1B Q9Y6F8 1/20 0.40
MEN1 O00255 1/20 0.40
XBP1 P17861 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14457628 0.84 ELANE (0.43) CNR1GPR55PKMMAPTLMNA
SCHEMBL5659465 0.84 CNR1 (0.55) CNR1GPR55KDM4EALDH1A1CBX7
SCHEMBL5661596 0.83 CNR1 (0.42) CNR1GPR55PKMMAPTLMNA
SCHEMBL30929657 0.83 CNR1 (0.42) CNR1GPR55PKMMAPTLMNA
SCHEMBL492340 0.81 GPR55 (0.67) CNR1GPR55PKMMAPTLMNA
SCHEMBL29394877 0.81 GPR55 (0.67) CNR1GPR55PKMMAPTLMNA
SCHEMBL5659701 0.81 PGR (0.44) CNR1GPR55PKMMAPTLMNA
SCHEMBL5659374 0.81 PGR (0.42) CNR1GPR55PKMMAPTLMNA
SCHEMBL29083889 0.80 MAPT (0.58) CNR1GPR55PKMMAPTLMNA
SCHEMBL13471422 0.79 CNR1 (0.72) CNR1GPR55PKMMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators NR3C2, NR5A1, NR5A2 CNR1 362/4885GPR55 77/4885PKM 1991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.